Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Stem Cell Research in Ophthalmology - Regenerating the Anterior Cornea Through Standardized Transplantation of Limbal Epithelial Stem Cells: a Phase II Multicenter Trial

NCT02318485 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT02318485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02318485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Stem Cell Research in Ophthalmology - Regenerating the Anterior Cornea Through Standardized Transplantation of Limbal Epithelial Stem Cells: a Phase II Multicenter Trial
Lead sponsor
University Hospital, Antwerp
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2015
Completion date
April 22, 2024
Enrollment
27 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

limbal stem cell deficiency